home
investors
newsroom
licensing
careers
contact us
About Us
Our Values
Leadership
How We Operate
Views and Positions
Merck/Schering-Plough Merger
Our History
Corporate Responsibility
Ethics and Transparency
Access
Environment
Community
Research
Pipeline
Discovery & Development
Products
Vaccines
Prescription Products
Consumer Products
Animal Health
Prescribing Information
INVESTED IN
YOUR FUTURE
Financials
Annual Reports, Proxy Statements, and Form 10-K
SEC Filings & Certifications
Earnings Releases
Quarterly Financials
Stock Information
Stock Chart
Historical Price Lookup
Stock Splits
Cash Dividend History
Investment Calculator
Partnerships
Events & Presentations
Stockholder Services
Information Request
Contact Us
LATEST NEWS
Nov. 24, 2009
Merck Announces Quarterly Dividend and New $3 Billion Share Repurchase Program
Nov. 23, 2009
Merck Wins Summary Judgment in Second Federal Bellwether Case Involving FOSAMAX® (alendronate sodium)
Nov. 23, 2009
Merck Statement on Article in The Archives of Internal Medicine Involving VIOXX®
More news
Print
Share
Text Size
Product Pipeline
Learn more
Related Information
2008 Merck Annual Report
2008 Schering-Plough Annual Report
Corporate Responsibility Report
Podcast
